Replimune Group, Inc. director Kapil Dhingra sells $408,500 of REPL stock
After the sale, the filing lists 21,669 shares held.
A Form 4 filed on Nov 3 shows Kapil Dhingra (Director) selling 21,500 Replimune Group, Inc. shares worth $408,500 on Nov 2.
The filing does not mark the sale as made under a Rule 10b5-1 trading plan. The trade was reported within two business days, as Section 16 requires.
After the trade, the filing lists 21,669 shares held.
Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.
| Company | Replimune Group, Inc. (REPL) |
|---|---|
| Insider | Kapil Dhingra |
| Role | Director |
| Transaction | Open-market sale (code S) |
| Shares | 21,500 |
| Average price | $19.00 |
| Value | $408,500 |
| Trade date | Nov 2, 2026 |
| Filed with the SEC | Nov 3, 2026, 8:43 PM ET |
| Shares held after | 21,669 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
See the full details of this insider trade
See the latest cluster buys and sells · See earlier insider stories on Replimune Group, Inc.
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
